Investors Should Be Paying Close Attention to This Industry

CORAL GABLES, FL / ACCESSWIRE / April 22, 2019 / Investors should be paying close attention to the cannabis industry right now. Canada has already gone fully legal and the US does not appear to be far behind. Currently, recreational marijuana is now legal in 10 US states & medical marijuana is legal in 33 US States. Even CBD, the non-psychoactive chemical in cannabis, has gotten the green light to be legally sold across all 50 US states and big-box retail stores like Walgreens and CVS are beginning to carry CBD products. This positive momentum within the USA and Canada has investors asking, "What pot stocks should I be watching right now?"

Today we are highlighting: Canopy Growth Corporation (CGC) / (TSX:WEED.TO), Aphria Inc. (APHA), Aurora Cannabis Inc. (ACB), Leafbuyer Technologies, Inc. (LBUY).

Canopy Growth Corporation (CGC) (WEED.TO) (Market Cap: $16.233B) broke barriers in 2017 and 2018, and will likely continue into 2019. The original deal between the fortune 500 company, Constellation Brands and Canopy Growth set the framework for the cannabis industry to enter "The Real World." Constellation Brands, one of the largest alcohol producers in the world entered into and then expanded upon a multi-billion dollar deal with Canopy and now owns a significant stake in the company.

Canopy Growth Corporation (CGC) (WEED.TO) and Constellation Brands have signed a deal to revise some of their warrants in light of the latest plan for Canopy to acquire Acreage Holdings. "Today we announce a complex transaction with a simple objective. Our right to acquire Acreage secures our entrance strategy into the United States as soon as a federally-permissible pathway exists," stated Bruce Linton, the co-CEO of Canopy Group. As of this report, CGC stock is up by nearly 6%.

________

Aphria Inc. (APHA) (Market Cap: $1.964B) has started to climb in price on April 22, 2019. Shares of Aphria were up as high as $7.80 before the lunch hour.

Last week on 4/17/2019 Aphria Inc. (APHA) released less than favorable news announcing the pricing of a US$300 million aggregate principal amount of 5.25% convertible senior notes due 2024 (the "notes") in a private placement to qualified institutional buyers pursuant to Rule 144A under the U.S. Securities Act of 1933, as amended (the "Act"), and outside the United States to non-U.S. persons in compliance with Regulation S under the Act. Aphria also granted the initial purchasers of the notes an option, exercisable within a 30-day period, to purchase up to an additional US$50 million aggregate principal amount of notes. The sale of the notes to the initial purchasers is expected to settle on April 23, 2019, subject to the satisfaction of customary closing conditions.

Shortly after on 4/18/2019 Aphria Inc. (APHA) announced that its German subsidiary Aphria Deutschland GmbH ("Aphria Germany") has secured the previously announced license for the domestic cultivation of medical cannabis from the German Federal Institute for Drugs and Medical Devices ("BfArM"), following the conclusion of a mandatory 10-day standstill period for public contracts. Aphria was granted a cultivation license for four of the nine total lots awarded by BfArM and is awaiting the completion of the tender process for the four remaining lots under review, one of which was provisionally awarded to Aphria Germany.

________

Aurora Cannabis Inc. (ACB) (Market Cap: $9.243B) has begun to see a positive move after making some key announcements, recently. For starters, Bank of America initiated coverage on Aurora Cannabis Inc. (ACB) with a target price of $11USD, but the company also released an update about its German operation, stating that its contract with the German Federal Institute for Drugs and Medical Devices has been finalized. This approval allows the Aurora Cannabis to start building its new indoor cannabis production facility in Leuna, Germany next month, May 2019, with the expected completion being anticipated within 12 months from groundbreaking.

________

Leafbuyer Technologies (LBUY) (Market Cap: $47.205B) announced on 4/10/2019 that it booked a 36% cash sales growth in its last quarter. This increase comes after reported record sales growth for the quarter ended December 31, 2018.

Growth and expansion appear to be a primary focus for Leafbuyer Technologies (LBUY). Within the last 3 months, Leafbuyer has been able to sign 50 Oklahoma dispensary clients, reach tens of thousands of new users for its Greenlight Platform, and launch a West Coast regional office, which is in addition to its Denver, CO headquarters.